Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANTHONY SEBBA

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1629077243
CMS profile
1178088
Location
PALM HARBOR, FL

General Payments · PY2018–2024

$830,608.86

  • Reported across 1,072 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$29,897.87

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $27,975.90 29
Fresenius Kabi USA, LLC $1,875.00 1
Janssen Biotech, Inc. $28.73 1
Lilly USA, LLC $18.24 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $253,241.52 347
PY2019 $263,229.40 347
PY2020 $82,908.45 62
PY2021 $54,467.62 59
PY2022 $75,785.78 137
PY2023 $71,078.22 88
PY2024 $29,897.87 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Fresenius Kabi USA, LLC $1,875.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1146944909 CMS
GENZYME CORPORATION $248.34 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1139576867 CMS
GENZYME CORPORATION $173.34 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1139576869 CMS
GENZYME CORPORATION $107.68 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1139576871 CMS
GENZYME CORPORATION $72.12 01/26/2024 Food and Beverage Undisputed 01/23/2026 1139576873 CMS
GENZYME CORPORATION $35.39 01/26/2024 Food and Beverage Undisputed 01/23/2026 1139576875 CMS
GENZYME CORPORATION $50.13 01/26/2024 Food and Beverage Undisputed 01/23/2026 1139576877 CMS
GENZYME CORPORATION $80.03 01/26/2024 Food and Beverage Undisputed 01/23/2026 1139576879 CMS
GENZYME CORPORATION $48.00 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1139576881 CMS
GENZYME CORPORATION $24.52 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1139576883 CMS
GENZYME CORPORATION $5,088.00 01/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139576895 CMS
GENZYME CORPORATION $93.95 02/09/2024 Food and Beverage Undisputed 01/23/2026 1139576825 CMS
GENZYME CORPORATION $43.53 04/15/2024 Food and Beverage Undisputed 01/23/2026 1139576841 CMS
GENZYME CORPORATION $13.80 04/16/2024 Food and Beverage Undisputed 01/23/2026 1139576897 CMS
GENZYME CORPORATION $7,950.00 04/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139576899 CMS
GENZYME CORPORATION $316.70 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1139576901 CMS
GENZYME CORPORATION $1,088.99 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1139576903 CMS
GENZYME CORPORATION $60.00 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1139576905 CMS
GENZYME CORPORATION $51.45 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1139576907 CMS
GENZYME CORPORATION $2,862.00 04/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139576909 CMS
GENZYME CORPORATION $160.60 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1139576911 CMS
GENZYME CORPORATION $47.81 04/16/2024 Food and Beverage Undisputed 01/23/2026 1139576931 CMS
GENZYME CORPORATION $145.47 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1139576913 CMS
GENZYME CORPORATION $665.20 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1139576915 CMS
GENZYME CORPORATION $292.17 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1139576917 CMS
GENZYME CORPORATION $72.00 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1139576919 CMS
GENZYME CORPORATION $40.44 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1139576921 CMS
GENZYME CORPORATION $15.42 06/03/2024 Food and Beverage Undisputed 01/23/2026 1139576923 CMS
GENZYME CORPORATION $7,950.00 06/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139576925 CMS
GENZYME CORPORATION $178.82 06/03/2024 Food and Beverage Undisputed 01/23/2026 1139576929 CMS
Janssen Biotech, Inc. $28.73 01/23/2024 Food and Beverage Undisputed 01/23/2026 1078472802 CMS
Lilly USA, LLC $18.24 05/01/2024 Food and Beverage Undisputed 01/23/2026 1136048575 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.